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Lluís Ribas de Pouplana and Peter Dedon
This FEBS Letters “FOCUS ON…” series of short reviews on tRNA captures the essence of 
the Barcelona BioMed Conference on Gene Translation: Fidelity and Quality Control, 
which was held at the Institut d'Estudis Catalans in Barcelona on December 2–4, 2013. This 
meeting was powered by the dramatic resurgence of interest in tRNA biochemistry 
following the realization that tRNA is much more than a simple adaptor of the genetic code.
This realization stems in part from the emergence of new convergent technologies, such as 
deep sequencing, bioinformatics, biological mass spectrometry and ‘omic science, as well as 
from the growing body of evidence that connects translation biology to the cell cycle, 
metabolism and disease. Research on translation has long focused on the interactions 
between the basic players of translation (tRNA, aminoacyl-tRNA synthetases, transcripts 
and ribosomes), but these interactions were mainly studied in isolation from the rest of the 
cell. However, tRNAs have now emerged as key players in the many mechanisms of control 
that tightly couple protein synthesis to the main signaling pathways that modulate cell 
biology and pathophysiology. Recent discoveries on the connections between tRNAs and 
signaling pathways and cell function have highlighted the need to establish a fluid dialogue 
among laboratories that approach the problem from its many different perspectives.
The Barcelona BioMed Conference recognized and consolidated these emerging ideas and 
discoveries, the scientific substance of which is reflected in the five mini-reviews of this 
“FOCUS ON…” series. A major focus was the growing area of tRNA mistranslation (see 
also Moghal et al.), from the perspective of pathological errors in protein sequences due to 
mischarging of tRNAs, to the concept of “adaptive mistranslation” as a stress response and 
survival mechanism for many organisms. Another emerging topic was the role of anticodon 
modifications and their effects upon codon usage patterns and codon-biased translation in 
cell stress responses and pathophysiology (Begley and Dedon). A third area of interest was 
discoveries of direct mechanistic links between human diseases, such as cancer and 
neurodegeneration, and facets of tRNA biology including tRNA modification and 
maturation (Torres et al.), tRNA cleavage (Anderson and Ivanov) and aminoacyl-tRNA 
synthetases (Laporte et al.).
While the meeting successfully accomplished the objective of bringing together a diverse 
group of scientists to discuss the present and the future of tRNA research, this FOCUS 
ON…series reflects its scientific substance, as well as the excitement still resonating among 
those who attended the conference. As co-organizers of this meeting and editors of the 
FOCUS ON…, we hope that you might share the excitement about these new developments 
in tRNA biology.
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